Correlation Between Acumen Pharmaceuticals and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Aquestive Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Aquestive Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Aquestive Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acumen and Aquestive is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Aquestive Therapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Aquestive Therapeutics. In addition to that, Acumen Pharmaceuticals is 1.15 times more volatile than Aquestive Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 92.00 in Aquestive Therapeutics on September 4, 2024 and sell it today you would earn a total of 389.00 from holding Aquestive Therapeutics or generate 422.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Aquestive Therapeutics
Performance |
Timeline |
Acumen Pharmaceuticals |
Aquestive Therapeutics |
Acumen Pharmaceuticals and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Aquestive Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.Acumen Pharmaceuticals vs. Candel Therapeutics | Acumen Pharmaceuticals vs. Cingulate Warrants | Acumen Pharmaceuticals vs. Unicycive Therapeutics | Acumen Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |